Convergent hybrid ablation is an innovative treatment for a type of irregular heart rhythm called atrial fibrillation (AFib). The treatment is a two-stage procedure that combines the expertise of our ...

Please provide your email address to receive an email when new articles are posted on . “Cryoconvergent” hybrid ablation for atrial fibrillation may significantly reduce risk for recurrent AF and AF ...

DENVER (CBS4) - Almost three million people in the U.S. suffer from atrial fibrillation, a type of irregular heartbeat. It can cause shortness of breath and is a leading cause of stroke. CBS4 Health ...

In patients with atrial fibrillation, the upper chambers of the heart beat out of rhythm. With difficult to treat cases, patients chose between two solutions: scarring the heart from inside with an ...

Doctors at Genesys Heart Institute in Grand Blanc Township are performing a new procedure to treat patients with persistent atrial fibrillation. GRAND BLANC TWP, MI – Doctors at Genesys are performing ...

Indianapolis - There is a new way to treat an irregular heartbeat. The St. Vincent Heart Center of Indiana was the first in the state to perform what's called a convergent procedure. It's a hybrid ...

ZANESVILLE − Genesis HealthCare System’s cardiothoracic and electrophysiology surgery teams recently performed their first convergent procedure. It can reduce the risk of stroke and eliminate blood ...

Parkridge Medical Center became the first hospital in Chattanooga to offer the Convergent Procedure as a treatment for persistent atrial fibrillation, the most prevalent heart rhythm disorder and a ...

St. Vincent’s Medical Center Riverside is enrolling Jacksonville residents who experience persistent atrial fibrillation (AFib) and have not responded to other treatments in a national clinical trial.

Dr. HelenMari Merritt-Genore, a cardiothoracic surgeon with Methodist Physicians Clinic, performs the surgical portion of a Convergent procedure. Nate Ostrand rides his bike in Omaha's Stinson Park.

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced the results ...